FDA inspection
Rentschler Biopharma Inc.: FDA inspection ending Jan 17, 2025
FDA inspection 1259307 · Voluntary Action Indicated (VAI) · Milford, MA
Key facts
| Inspection ID | 1259307 |
|---|---|
| Firm | Rentschler Biopharma Inc. |
| FEI number | 3003282293 |
| Address | 27 Maple St |
| City | Milford |
| State | MA |
| ZIP | 01757 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Jan 17, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data